Quest PharmaTech Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QPTFF research report →
Price Chart
About the company
Quest PharmaTech Inc. (QPTFF), an Edmonton, Canada-based pharmaceutical firm, specializes in creating antibody-driven immunotherapeutic remedies primarily for various cancers. A cornerstone of its product pipeline is Mab AR 9.
- CEO
- Ragupathy Madiyalakan
- IPO
- 2018
- Employees
- 3
- HQ
- Edmonton, AB, CA
Get TickerSpark's AI analysis on QPTFF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.38M
- P/E
- 0.99
- PEG
- -0.00
- P/S
- 0.00
- P/B
- 0.18
- EV/EBITDA
- 12.80
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 21.70%
- ROIC
- -2.18%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-712,378
- Net Income
- $5.01M+378.0%
- EPS
- $0.03+505.5%
- OCF Growth
- +62.7%
- FCF Growth
- +62.7%
- 52W High
- $0.03
- 52W Low
- $0.01
- 50D MA
- $0.02
- 200D MA
- $0.02
- Beta
- -0.30
- RSI (14)
- 2
- Avg Volume
- 7.26K
No earnings-call transcripts are available for QPTFF yet.
- Free Float
- 82.0%
- Shares Outstanding
- 169.13M
- Float Shares
- 138.75M
Our QPTFF coverage
Recent articles, reports, and earnings notes.
No research on QPTFF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate QPTFF report →Quest PharmaTech Announces Results from AGM
globenewswire.com · Aug 27
Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech
globenewswire.com · Jun 10
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.